These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 12897781)

  • 21. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computing the structure of bound peptides. Application to antigen recognition by class I major histocompatibility complex receptors.
    Rosenfeld R; Zheng Q; Vajda S; DeLisi C
    J Mol Biol; 1993 Dec; 234(3):515-21. PubMed ID: 8254656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.
    Bjorkman PJ; Saper MA; Samraoui B; Bennett WS; Strominger JL; Wiley DC
    Nature; 1987 Oct 8-14; 329(6139):512-8. PubMed ID: 2443855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of the immunoregulatory receptor LILRB1 as a crystallisation chaperone for human class I MHC complexes.
    Mohammed F; Stones DH; Willcox BE
    J Immunol Methods; 2019 Jan; 464():47-56. PubMed ID: 30365927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular comparisons of the beta 2-microglobulin-binding site in class I major-histocompatibility-complex alpha-chains and proteins of related sequences.
    Tysoe-Calnon VA; Grundy JE; Perkins SJ
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):359-69. PubMed ID: 1859364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2.
    Valés-Gómez M; Shiroishi M; Maenaka K; Reyburn HT
    J Virol; 2005 Feb; 79(4):2251-60. PubMed ID: 15681427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance.
    Cheng H; Mohammed F; Nam G; Chen Y; Qi J; Garner LI; Allen RL; Yan J; Willcox BE; Gao GF
    J Biol Chem; 2011 May; 286(20):18013-25. PubMed ID: 21454581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection.
    Pizzato N; Garmy-Susini B; Le Bouteiller P; Lenfant F
    J Reprod Immunol; 2004 Jun; 62(1-2):3-15. PubMed ID: 15288176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site.
    Collins EJ; Garboczi DN; Wiley DC
    Nature; 1994 Oct; 371(6498):626-9. PubMed ID: 7935798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin.
    Achour A; Michaëlsson J; Harris RA; Ljunggren HG; Kärre K; Schneider G; Sandalova T
    J Mol Biol; 2006 Feb; 356(2):382-96. PubMed ID: 16375919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2.
    Thilo C; Berglund P; Applequist SE; Yewdell JW; Ljunggren HG; Achour A
    J Biol Chem; 2006 Mar; 281(13):8950-7. PubMed ID: 16452487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.
    Ryu M; Chen Y; Qi J; Liu J; Fan Z; Nam G; Shi Y; Cheng H; Gao GF
    PLoS One; 2011 Apr; 6(4):e19245. PubMed ID: 21559424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules.
    Cosman D; Fanger N; Borges L; Kubin M; Chin W; Peterson L; Hsu ML
    Immunity; 1997 Aug; 7(2):273-82. PubMed ID: 9285411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I.
    Maenaka K; Juji T; Stuart DI; Jones EY
    Structure; 1999 Apr; 7(4):391-8. PubMed ID: 10196125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta(2)m as a fusion protein in Escherichia coli.
    Ren D; Wang F; He X; Jiang L; Li D; Ying H; Sun S
    Protein Expr Purif; 2006 Dec; 50(2):171-8. PubMed ID: 17046278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
    Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
    Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
    Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
    J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel domain on HLA-DRbeta chain regulates the chaperone role of the invariant chain.
    Neumann J; Koch N
    J Cell Sci; 2006 Oct; 119(Pt 20):4207-14. PubMed ID: 16984974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability engineering, biophysical, and biological characterization of the myeloid activating receptor immunoglobulin-like transcript 1 (ILT1/LIR-7/LILRA2).
    Chen Y; Chu F; Gao F; Zhou B; Gao GF
    Protein Expr Purif; 2007 Dec; 56(2):253-60. PubMed ID: 17920929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A HLA-Cw6 specific single-chain antibody fragment (scFv) recognizing a natural killer cell receptor epitope.
    Marget M; Bohlsen D; Davarnia P; Yoo-Ott K; Kabelitz D; Skerra A; Steinmann J
    Mol Immunol; 2005 Mar; 42(5):643-9. PubMed ID: 15607823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.